Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction (Q46607952)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction |
scientific article published in June 2005 |
Statements
1 reference
Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction (English)
1 reference
Hartmut Vatter
1 reference
Michael Zimmermann
1 reference
Veronika Tesanovic
1 reference
Andreas Raabe
1 reference
Lothar Schilling
1 reference
Volker Seifert
1 reference
1 June 2005
1 reference
102
1 reference
6
1 reference
1101-1107
1 reference